XML 52 R29.htm IDEA: XBRL DOCUMENT v3.24.0.1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Compensation  
Schedule of Restricted Stock Units

 

 

For the Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

 

Number of Shares

 

 

Weighted-Average Grant Date Fair Value Per Share

 

 

Number of Shares

 

 

Weighted-Average Grant Date Fair Value Per Share

 

Unvested balance at January 1

 

 

160,000

 

 

$12.08

 

 

 

-

 

 

$-

 

RSUs granted

 

 

870,200

 

 

$3.46

 

 

 

266,666

 

 

$29.45

 

RSUs vested

 

 

(44,680)

 

$13.11

 

 

 

(106,666)

 

$55.5

 

RSUs forfeited

 

 

(31,214)

 

$5.28

 

 

 

-

 

 

$-

 

Unvested balance at December 31

 

 

954,306

 

 

$4.39

 

 

 

160,000

 

 

$12.08

 

Summary of option activity

 

 

Number of Shares

 

 

Weighted-Average Exercise Price Per Share

 

 

Weighted-Average Remaining Contractual Term (in years)

 

 

Aggregate Intrinsic Value

 

Outstanding at January 1, 2022

 

 

7,332

 

 

$28.50

 

 

 

9.3

 

 

 

-

 

Granted

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Forfeited or expired

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Outstanding at December 31, 2022

 

 

7,332

 

 

 

28.50

 

 

 

8.3

 

 

 

-

 

Granted

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Forfeited or expired

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Outstanding at December 31, 2023

 

 

7,332

 

 

$28.50

 

 

 

7.3

 

 

$-

 

Vested or expected to vest at December 31, 2023

 

 

7,332

 

 

$28.50

 

 

 

7.3

 

 

$-

 

Exercisable at December 31, 2023

 

 

5,110

 

 

$28.50

 

 

 

7.2

 

 

$-

 

Schedule of share-based compensation expense

 

 

For the Year Ended December 31,

 

 

 

2023

 

 

2022

 

Selling, general and administrative expenses

 

$875,509

 

 

$6,394,198

 

Research and development expenses

 

 

220,723

 

 

 

24,232

 

Cost of revenues

 

 

18,535

 

 

 

3,449

 

Total

 

$1,114,767

 

 

$6,421,879